FGFR2 has been reported to act as an oncogene in breast cancer and increased FGF signalling might promote cancer initiation or progression by protecting the cells from apoptosis [28] and stimulating growth and proliferation [29]. The gene discussed is FGFR2; the disease is breast cancer.